Objective: The objective of this study was to investigate the molecular mechanisms underlying adenovirus-36 (Ad-36)-induced obesity by the identification of novel genes and cellular pathways. Design: Viral growth, intracellular lipid accumulation and gene expression profiles were determined in human mesenchymal stem cells (hMSCs) infected with Ad-36 or Ad-2. A microarray assay and gene set enrichment analysis (GSEA) were performed to assess alterations in global gene expression profiles. Results: Ad-36, but not Ad-2, induced lipid accumulation and upregulated adipogenesis-related genes. There was no difference in viral growth between Ad-36 infection and Ad-2 infection in hMSCs. GSEA revealed that Ad-36 infection was more frequently associated with activation of novel pathways, including the PPAR-gamma signaling pathway, and inflammation compared with Ad-2 infection, raising the possibility that these pathways may be key regulators of Ad-36-induced adipogenesis. Conclusion: This study may help foster a better understanding of the roles of several cellular factors in Ad-36-induced obesity.
Introduction
Obesity is one of the top health problems in the world. The causes of obesity include heredity, food intake, exercise, environment and psychology. Recently, it was revealed that obesity is associated with several pathogens, such as adenovirus-36 (Ad-36), Ad-37, SMAM-1, scrapie and Chlamydia pneumonia.
1,2 Most importantly, the relationship between Ad-36 and human obesity, as well as obesity in mice, chickens, rhesus monkeys, marmosets and rats, is well known. 3, 4 Moreover, a study performed on American adult human samples, using serology to determine previous exposure to Ad-36, showed that 30% of the obese individuals were antibody-positive compared with 11% of the non-obese subjects. 5 A pediatric study in Korea revealed that a larger number of obese subjects tested positive for the Ad-36
antibody than non-obese subjects (28.57 vs 13.56%, respectively; P ¼ 0.0174). 6, 7 In addition, other studies using the Italian and the US children and adolescents demonstrated the association between the Ad-36 antibody and obesity. 8, 9 Currently, little is known about the cellular and molecular mechanisms underlying Ad-36-induced obesity. Recently, Ad-36 E4 orf-1 was identified as a novel inducer of the rodent and human adipocyte differentiation process. 10 In addition, it increases glucose uptake via the upregulation of the glucose transporter 4 in human skeletal muscle cells and human adipose tissue-derived stem cells. 11, 12 However, it remains unclear which cellular and viral factors are involved in Ad-36-induced obesity or adipogenesis. The lack of proper model systems to analyze the signal pathways and genetic profiles involved in Ad-36-induced obesity may be one of the reasons for this uncertainty. Human preadipocytes derived from adipose tissue are widely used to study human adipogenesis. 12 However, these cells are already committed to the adipogenic lineage. Moreover, human preadipocytes have limited proliferative ability, an unforeseeable variability (based on different donors and anatomical sites) and confined availability. 12 Human bone marrow mesenchymal stem cells (hMSCs) are multipotent stem cells that can be induced to differentiate into adipocytes, osteoblasts, chondrocytes and myoblasts when cultured under defined in vitro conditions. 13, 14 Previous reports showed the specific gene profiles during the process of differentiating hMSCs to adipocytes using adipogenic induction medium. 15 In this study, we found that hMSCs differentiated to adipocytes when cells were infected with Ad-36 without the use of adipogenic induction medium. We also identified entire gene expression profiles using microarray analysis. To explore novel cellular pathways that are activated by Ad-36, we performed gene set enrichment analysis (GSEA). It showed that infection with Ad-36 activated pathways of PPAR-gamma signaling and inflammation in hMSCs, providing novel insights into Ad-36-induced obesity. Overall, our results suggest that hMSCs represent an optimal surrogate module to study Ad-36-induced adipogenesis. Moreover, several of the cellular gene sets that were upregulated in Ad-36-infected hMSCs may provide clues regarding the cellular mechanisms involved in Ad-36-induced obesity.
Materials and methods
Human bone marrow mesenchymal stem cells Human bone marrow mesenchymal stem cells were acquired from the Ewha Womans University Medical School (Dr Jo Inho, Department of Molecular Medicine) and cultured in Dulbecco's Modified Eagle's Medium (Hyclone, Rockford, IL, USA) containing 10% fetal bovine serum (Hyclone) and 1% antibiotics (Hyclone) at 37 1C and 5% CO 2 . Cells from passages 2 to 4 were used for experiments.
Viruses and infection
Ad-36 and Ad-2 were obtained from the American Type Culture Collection (Manassas, VA, USA; Cat no. VR-913 and VR-846), plaque purified and propagated in A549 cells (a human lung cancer cell line), as described previously. 5 Viral titers were determined using a plaque assay. 16 Samples for microarray assay were prepared as follows: B80% confluent hMSCs were starved overnight and infected with a multiplicity of infection of 4 of Ad-36 and Ad-2 in serumfree Dulbecco's Modified Eagle's Medium for 1.5 h. hMSCs were switched to completed Dulbecco's Modified Eagle's Medium (10% fetal bovine serum and 1% antibiotics). At 1 and 2 days later, hMSCs were washed twice with phosphatebuffered saline, lifted using cell scrapers, collected by centrifugation (12 000 r.p.m., 15 min, 4 1C) and subjected to RNA isolation as described below.
Neutral lipid staining hMSCs (80% confluent) cultured in six-well plates (Corning, New York, NY, USA) were infected with multiplicity of infection 4 of Ad-36 or Ad-2 and fixed 2 days later. The mock group was treated with phosphate-buffered saline. The cells were rinsed twice with phosphate-buffered saline and fixed with 4% paraformaldehyde for 10 min. The fixed cells were subjected to BODIPY using a modification of a protocol reported previously, 17 with BODIPY 493/503 (Invitrogen, Carlsbad, CA, USA; dilution, 1:1000). For Oil Red O staining, we discarded media and added 2 ml of 10% formalin, followed by 30 min incubation at room temperature. The Oil Red O stock solution was prepared by dissolving 300 mg of Oil Red O powder (Sigma, Ronkonkoma, NY, USA) in 100 ml of 99% isopropanol. The fixed cells grown in six-well plates were treated with 60% isopropanol (2 ml per well) for 5 min. The isopropanol was removed, 2 ml of the Oil Red O working solution was added to each well for 2 h, and cells were incubated at room temperature and then washed with tap water.
RNA isolation and cDNA synthesis
All procedures were performed according to those of previous reports. 11 RNA was extracted from cells using the TRIzol reagent (Invitrogen). Purified RNAs were stored at À80 1C until use. For cDNA synthesis, 5 ml RNA, 1 ml oligo-dT, 2 ml DTT, 4 ml distilled water and 8 ml of a Master Mix for the Reverse Transcription step (RT&GO, MP Biomedicals, Solon, OH, USA) were mixed and RT-PCR was performed (Thermocycler; Biometra, Goettingen, Germany).
Microarray assay
Human Expression BeadChips were designed using Illumina BeadArray technology (Illumina, San Diego, CA, USA). A mock chip (non-infected hMSCs) was selected as a standard. Gene expression profiles from test samples were compared with the standard. For analysis, we compared the Ad-36 and mock gene sets at 1 and 2 days after infection. We also carried out experiments for Ad-2 using the same conditions and identified changes in gene expression.
Gene set enrichment analysis
To explore pathways that were regulated differentially by Ad-36 and Ad-2 in hMSCs, we performed GSEA using the microarray data, as described previously 18 using a GSEA program (http://www.broad.mit.edu/gsea/msigdb/index.jsp). We used C2-curated gene sets (http://www.broadinstitute. org/gsea/msigdb/collections.jsp#C2, version 2.5) with a size of 15-1000 genes. Po0.05 was considered significant.
Results
Absence of difference in viral growth between Ad-36-and Ad-2-infected hMSCs First, we evaluated viral replication in hMSCs, as we had to demonstrate that all phenotypic differences observed between Ad-36-and Ad-2-infected cells stemmed from intrinsic characteristics of the viruses and not from efficiency Molecular mechanism of Ad-36-induced obesity H-N Na et al of viral replication or viral infection. There were no differences between the extracellular and intracellular growth of the Ad-36 and Ad-2 viruses in hMSCs (Figure 1 ), suggesting that any differential phenotypes observed in cells was not caused by differences in viral growth between Ad-36 and Ad-2.
Ad-36, but not Ad-2, induced adipogenic differentiation of hMSCs Cell morphology and lipid accumulation were assessed at 6, 24 and 48 h after infection of hMSCs with multiplicity of infection of 4 of Ad-36 and Ad-2. Only Ad-36-infected, but not Ad-2-or mock-infected, hMSCs underwent morphological changes into more rounded shapes. In addition, there was an increase in the number of cells containing lipid droplets, exclusively in Ad-36-infected hMSCs, which was confirmed by BODIPY and Oil Red O staining ( Figure 2a) . Next, we quantified adipogenic differentiation by counting BODIPY-positive cells. The number of BODIPY-positive cells was two-, three-and fourfold higher at 6, 24 and 48 h, respectively, in hMSCs infected with Ad-36 compared with the mock (Po0.012, Po0.001 and Po0.0003, respectively), whereas there was no difference in the number of BODIPYpositive cells between the mock and Ad-2-infected cells (Figure 2b ). These data suggest that Ad-36, but not Ad-2, induces the adipogenic differentiation of hMSCs.
Ad-36 infection upregulated adipogenesis-related genes in hMSCs Next, we performed a microarray assay to determine the effect of Ad-36 and Ad-2 infection on gene expression in hMSCs, especially regarding genes involved in adipogenesis.
No global difference was observed in terms of the total gene expression profiles between Ad-36-and Ad-2-infected hMSCs (Supplementary Figure 1) . However, the profiles of obesityrelated genes were more up-and downregulated after infection with Ad-36 than with Ad-2; 296 genes related to obesity showed changes in expression during adipogenesis (Supplementary Figure 2) . The microarray data revealed that several obesity-related genes were upregulated during Ad-36 infection compared with Ad-2 infection (Table 1 ). The upregulation of some genes after Ad-36 infection was confirmed using semi-quantitative real-time RT-PCR (data not shown). Interestingly, the comparison of the microarray Supernatants and hMSCs were collected at 6, 12, 24 and 48 h after infection with multiplicity of infection of 4 of viruses to determine the extracellular and intracellular virus titers, respectively. The hMSCs collected were washed with phosphate-buffered saline and subjected to three cycles of freeze-thaw to release intracellular viruses. The titer of extracellular and intracellular viruses was quantified using a plaque assay. Molecular mechanism of Ad-36-induced obesity H-N Na et al data obtained in this study with gene profiles reported previously, which were determined after inducing mediatreated hMSCs to adipocytes, 15 revealed that 35 genes were similarly upregulated in Ad-36 infection and in induced adipogenesis; these included LPL, ATF3, FABP4, C/EBPa and C/EBPg (Figure 3 ). This indicated that the 35 upregulated genes (listed in Supplementary Table 1) may be essential for the differentiation of hMSCs to adipocytes.
GSEA identified novel pathways that were regulated selectively by Ad-36 compared with Ad-2 We explored novel pathways that were regulated selectively by Ad-36 compared with Ad-2 using GSEA as previously described. 18 Interestingly, GSEA revealed that Ad-36 significantly increased PPAR-gamma signaling pathways (Po0.05) and inflammation pathways (Po0.01) compared with Ad-2 ( Figure 4) , which raises the possibility that Ad-36 activates these two pathways selectively compared with Ad-2. These two pathways may be key regulators of Ad-36-induced adipogenesis in hMSCs. Subsequently, we performed a leading-edge subset analysis to identify the core genes involved in the PPAR-gamma signaling pathway and in the inflammation pathway. Activation of PPAR-gamma pathways was associated with selective upregulation of eight genes, including uncoupling protein 1 (UCP-1), and the activation of inflammation pathways was linked with the upregulation of three genes, including interleukin-11 ( Figure 4) .
Discussion
Many previous studies showed that Ad-36 infection increases body weight and visceral, epididymal, inguinal and retroperitoneal fats, as well as the number of fat cells in rats, 19 chickens, 4 and rhesus and marmoset monkeys. 20 According to the results of an in vitro study, Ad-36 E4 orf-1 is one of the viral factors that are involved in Ad-36-induced adipogenesis. 10 However, the exact cellular and molecular mechanisms involved in this phenomenon have not been identified. Here, we found that hMSCs had the ability to differentiate into adipocytes after Ad-36 infection (Figure 2a) . Despite the absence of differences in viral growth between cells infected with Ad-36 or Ad-2 (Figure 1) , only Ad-36-infected hMSCs differentiated into adipocytes. Given that undifferentiated hMSCs can be induced to differentiate into adipocytes, hMSCs may represent a good model for the study of Ad-36-induced adipogenesis.
Ad-36 infection upregulated several obesity-related genes (Table 1) . Among them, UCP-1 is a member of the mitochondrial anion-carrier protein family and functions to dissipate undue energy. 21 Therefore, it is possible that Ad-36 may regulate the energy balance via UCP-1 to energy expenditure for obesity. In addition, it is well known that C/EBPa and PPARg have a decisive role in the differentiation of hMSCs to adipocytes. 22 Interestingly, Ad-36 infection also upregulated C/EBPa and PPARg in hMSCs (Table 1 , Supplementary Figure 2 ), suggesting that upregulation of these two genes contributes to Ad-36-induced adipogenesis. 21 Moreover, FABP4, which encodes a lipid-transport protein expressed in adipocytes, 22 SORBS1, which encodes an insulin-signaling molecule, 23 and ADIPOQ, which encodes the insulin-sensitizing hormone adiponectin, were upregulated in Ad-36-infected hMSCs (Table 1, Figure 4b ). Previous reports showed that SORBS1 affects insulin sensitivity and glucose/lipid metabolism. 24, 25 In addition, adiponectin induces the PPAR-gamma pathway and increases hepatic insulin sensitivity, which translates into systemic improvements. [26] [27] [28] Therefore, these genes may have a function in the adipogenesis, energy expenditure, lipid transport and insulin sensitivity involved in Ad-36-induced obesity, thus Molecular mechanism of Ad-36-induced obesity H-N Na et al representing good clues regarding the mechanisms that underlie this phenomenon. However, further studies are necessary to identify the function of the genes that were regulated in Ad-36-induced obesity.
In this study, we used GSEA to explore novel pathways that were regulated differentially after infection of Ad-36 compared with Ad-2. As many biological processes, such as inflammation and adipogenesis, occur as a network of changes in the expression levels of many genes, the analysis of a few genes may not be sufficient to predict biological phenomena. The strategy described herein for the analysis of Ad-36-induced obesity aimed to identify individual genes that showed differences of expression between Ad-36 and Ad-2 infection. However, it is difficult to detect biological processes, which are distributed across entire networks of genes, and subtle changes at the level of individual genes. GSEA, a tool used to analyze entire genetic networks, revealed the upregulation of the PPAR-gamma signaling pathway and that of the inflammation pathway (Figure 4 ).
It was expected to identify changed signals for the PPARgamma and inflammation pathways after Ad-36 infection, as previous reports showed that these two pathways are involved in obesity. 29, 30 The identification of the involvement of the inflammation pathway in Ad-36-induced obesity was interesting, given that inflammation in adipocytes is important for the maintenance of obesity states. 30 Moreover, many viruses lead to chronic inflammation states in infected hosts. [25] [26] [27] Interestingly, it has been reported that Ad-36 can infect human adipocytes. 12 Therefore, it is possible that Ad-36 induces inflammation, which in turn leads to obesity. In addition, we generated data that shows that Ad-36 infection increased some inflammatory factors in adipocytes (Na and Nam, unpublished data). Therefore, we can expect that the inflammation mechanisms involved in Ad-36 infection may provide new insights into Ad-36-induced obesity. Finally, GSEA seems very useful for the prediction of the cellular mechanisms involved in Ad-36-induced obesity and other diseases. Molecular mechanism of Ad-36-induced obesity H-N Na et al
Taken together, our results showed that Ad-36 induced the differentiation of hMSCs into an adipocyte lineage via the activation of specific genes and novel cellular pathways (PPAR-gamma and inflammation). Our study provides novel insights into Ad-36-induced obesity and suggests that hMSCs are a useful tool for the study of Ad-36-induced adipogenesis.
